Topical Drug Delivery Market To Rise Swiftly And Surpass USD 125 Billion By 2025 - Zion Market Research

Topical Drug Delivery Market

Topical Drug Delivery Market

The global topical drug delivery market was estimated at 94.6 (USD Billion) in 2019 and is projected to be valued at 125 (USD Billion) by 2025 at a CAGR of 5.7%

The global topical drug delivery market was estimated at 94.6 (USD Billion) in 2019 and is projected to be valued at 125 (USD Billion) by 2025 at a CAGR of 5.7%.”
— Zion Market Research

NEW YORK CITY, NEW YORK, UNITED STATES, February 10, 2020 /EINPresswire.com/ -- As per experts at Zion Market Research, in 2019 the topical drug delivery market was valued at USD 94.6 billion and is expected to cross USD 125 billion by 2025 with a 5.7% CAGR. High occurrence of burn injuries, high prevalence of eye & skin diseases, and the increasing occurrence of diabetes are driving the requirement for topical drug delivery. On the other hand, technical hurdles associated to permeability and skin irritation as well as product recalls and drug failures are the factors hampering the global market.

Major players active in the global topical drug delivery market are Nestle SA, Johnson & Johnson, GlaxoSmithKline, Novartis AG, Merck & Co, Bausch Health Companies, Hisamitsu Pharmaceutical, Bayer AG, Cipla Ltd, Glenmark Pharmaceuticals, Mylan, and Crescita Therapeutics Inc.

Semi-Solid Formulations Segment Ruled The Global Market In 2019

Based on product, the global market is divided into solid formulations (powders and suppositories), semi-solid formulations (gels, creams, pastes, ointments, and lotions), transdermal products (transdermal semi-solids and transdermal patches), and liquid formulations (suspensions and solutions). The semi-solid formulations section is anticipated to add up for the biggest share of market in forecast period. The benefits of semi-solid formulations such as higher patient acceptability topical gels and faster drug release along with wide applications of topical pastes for the prevention and treatment of skin irritation and high washability & spreadability of creams for the cure of different skin kinds are the factors boosting the market growth.

Get Free PDF Research Report Brochure for more Insights - https://www.zionmarketresearch.com/sample/topical-drug-delivery-industry

Homecare Settings To Add Up The Biggest Market Share In The Coming Years

Homecare settings segment added up for the biggest market share in 2018 and is expected to carry on the legacy. Home care settings removed the requirement for users to travel to healthcare facilities, therefore saving money and time. Due to this better affordability and convenience, a rising number of users prefer home-based treatments, and these are some of the major factors boosting the development of the global market.

North America Projected To Develop At The Highest CAGR In The Coming Years

North America ruled the global topical drug delivery market in 2018. And therefore, North America is anticipated to see the highest CAGR in the years to come. The increasing occurrence of skin diseases, launches & approvals of innovative topical formulations in the area, and financial support for the growth of topical drugs are some of the major factors boosting the development of this North America topical drug delivery market. For example, GlaxoSmithKline in December 2018 spent USD 36.0 million in making plants in Canada to support delivery and drive the manufacturing of VOLTAREN, its leading topical pain reliever.

Request for Discount or Customization on This Report - https://www.zionmarketresearch.com/custom/4763/news

This review is based on a report by Zion Market Research, titled “Topical Drug Delivery Market by Route (Ophthalmic, Dermal, Vaginal, Rectal, Nasal), Type (Liquids, Solids, Semisolids (Ointments, Creams, Lotions, Gels), Transdermal Products), Facility of Use (Hospital, Homecare, Burn Center) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025” report at https://www.zionmarketresearch.com/report/topical-drug-delivery-industry

The global topical drug delivery market is segmented as follows:

By Product

Semi-solid Formulations
Creams
Ointments
Lotions
Gels
Pastes

Liquid Formulations
Suspensions
Solutions

Solid Formulations
Powders
Suppositories
Transdermal Products
Transdermal Patches
Transdermal Semi-solids

By Route of Administration

Dermal Drug Delivery
Ophthalmic Drug Delivery
Rectal Drug Delivery
Vaginal Drug Delivery
Nasal Drug Delivery

By Facility of use

Homecare Settings
Hospitals & Clinics
Burn Centers
Other Facilities (academic & research institutes and diagnostic centers)

By Region

North America
U.S.

Europe
UK
France
Germany

Asia Pacific
China
Japan
India

Latin America
Brazil

Middle East and Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Kalpesh Deshmukh
Zion Market Research
+1 855-465-4651
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.